Explore the transformative potential of generative AI in enhancing market and competitive intelligence workflows, delivering faster and more accurate insights. This presentation will provide an overview of cutting-edge AI technologies, including Large Language Models (LLMs) and AI Agents, and their practical applications for understanding R&D pipelines and bringing treatments to market.
Key Topics Include:
- Generative AI and AI Agents: Transforming market analysis and forecasting
- Advanced AI tools: Smarter data extraction
- AlphaSense: The largest source of equity research and clinical trial reports
- Gen AI: Risks and benefits ahead
AlphaSense, an AI-powered market intelligence platform, enables executives to make confident, data-driven decisions with unparalleled speed. With the industry’s most comprehensive collection of equity research alongside company presentations and clinical trial data, AlphaSense delivers robust solutions for drug pipeline analysis, forecasting, and due diligence.
